We are live on ! Find out more
RCP

Remedium Capital Partners Portfolio holdings

AUM $452M
This Fund
S&P 500
This Quarter Est. Return
+35.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$111M
Cap. Flow
+$49.9M
Cap. Flow %
17.76%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
DMRA
Damora Therapeutics, Inc. Ordinary Shares
DMRA
+$49.5M
2
ORKA
Oruka Therapeutics
ORKA
+$460K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORKA
1
Oruka Therapeutics
ORKA
$7.16B
$76.8M 27.31%
1,565,661
+13,247
+0.9% +$460K
SYRE icon
2
Spyre Therapeutics
SYRE
$8.98B
$73.5M 26.13%
1,456,231
– –
DMRA
3
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
$53M 18.84%
2,045,473
+1,925,000
+1,598% +$49.5M
APGE icon
4
Apogee Therapeutics
APGE
$10.2B
$49.1M 17.47%
583,591
– –
JBIO
5
Jade Biosciences
JBIO
$1.51B
$22.2M 7.88%
1,577,750
– –
CBIO
6
Crescent Biopharma
CBIO
$618M
$6.64M 2.36%
361,250
– –

Similar funds

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
SIM
SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return
MC
Magnitude Capital New York $450M AUM 43.9% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return
EGP
Entrust Global Partners New York $456M AUM 26.51% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $456M AUM 60.63% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
OCM
Olstein Capital Management Purchase, New York $458M AUM 6.27% 1-Year Est. Return

Remedium Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Remedium Capital Partners held 6 positions worth $281M, up 65% from $170M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Remedium Capital Partners deployed $49.9M of net new capital in Q1 2026, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Remedium Capital Partners added most to Damora Therapeutics, Inc. Ordinary Shares in Q1 2026, an estimated $49.5M increase.
  • Remedium Capital Partners's ten largest holdings make up 100% of its $281M portfolio in Q1 2026.
  • Remedium Capital Partners opened 0 new positions and closed 0 in Q1 2026.
  • Remedium Capital Partners's portfolio value rose 65% quarter-over-quarter to $281M.

Based on Remedium Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.